Dire Medical: expects net losses of 22-33 million yuan in the first half of the year.

Derui Medical announced on July 22nd that it is expected to incur a net loss of 22-33 million yuan attributable to shareholders of the listed company in the first half of 2025, compared to a profit of 165 million yuan in the same period last year. The reasons for the performance change are a decrease in overall gross profit of the company, lower-than-expected installation and sales of the company's instruments and reagents in the domestic market, resulting in a significant decrease in the company's net profit level. Additionally, based on prudence, the company has made provisions for impairment of assets that show signs of impairment.